550 related articles for article (PubMed ID: 11943812)
1. A role for alpha-synuclein in the regulation of dopamine biosynthesis.
Perez RG; Waymire JC; Lin E; Liu JJ; Guo F; Zigmond MJ
J Neurosci; 2002 Apr; 22(8):3090-9. PubMed ID: 11943812
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.
Wu B; Liu Q; Duan C; Li Y; Yu S; Chan P; Uéda K; Yang H
Acta Histochem; 2011 Jan; 113(1):32-5. PubMed ID: 19683335
[TBL] [Abstract][Full Text] [Related]
3. Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
Perez RG; Hastings TG
J Neurochem; 2004 Jun; 89(6):1318-24. PubMed ID: 15189334
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.
Peng X; Tehranian R; Dietrich P; Stefanis L; Perez RG
J Cell Sci; 2005 Aug; 118(Pt 15):3523-30. PubMed ID: 16030137
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
8. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines.
Baptista MJ; O'Farrell C; Daya S; Ahmad R; Miller DW; Hardy J; Farrer MJ; Cookson MR
J Neurochem; 2003 May; 85(4):957-68. PubMed ID: 12716427
[TBL] [Abstract][Full Text] [Related]
9. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
Kirik D; Rosenblad C; Burger C; Lundberg C; Johansen TE; Muzyczka N; Mandel RJ; Björklund A
J Neurosci; 2002 Apr; 22(7):2780-91. PubMed ID: 11923443
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.
Yu S; Zuo X; Li Y; Zhang C; Zhou M; Zhang YA; Uéda K; Chan P
Neurosci Lett; 2004 Aug; 367(1):34-9. PubMed ID: 15308292
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity.
Zhou W; Freed CR
J Biol Chem; 2004 Mar; 279(11):10128-35. PubMed ID: 14699135
[TBL] [Abstract][Full Text] [Related]
13. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
Kim SS; Moon KR; Choi HJ
Arch Pharm Res; 2011 May; 34(5):837-45. PubMed ID: 21656370
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
Jorge-Finnigan A; Kleppe R; Jung-Kc K; Ying M; Marie M; Rios-Mondragon I; Salvatore MF; Saraste J; Martinez A
J Biol Chem; 2017 Aug; 292(34):14092-14107. PubMed ID: 28637871
[TBL] [Abstract][Full Text] [Related]
15. alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells.
Ahn BH; Rhim H; Kim SY; Sung YM; Lee MY; Choi JY; Wolozin B; Chang JS; Lee YH; Kwon TK; Chung KC; Yoon SH; Hahn SJ; Kim MS; Jo YH; Min DS
J Biol Chem; 2002 Apr; 277(14):12334-42. PubMed ID: 11821392
[TBL] [Abstract][Full Text] [Related]
16. Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells.
Liu D; Jin L; Wang H; Zhao H; Zhao C; Duan C; Lu L; Wu B; Yu S; Chan P; Li Y; Yang H
Neurochem Res; 2008 Jul; 33(7):1401-9. PubMed ID: 18357527
[TBL] [Abstract][Full Text] [Related]
17. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
[TBL] [Abstract][Full Text] [Related]
20. Selective alterations of gene expression in mice induced by MPTP.
Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
